Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: antide and hormone levels

By Huirne Judith A.F.   van Loenen Andre C.D.   Schats Roel   McDonnell Joseph   Hompes Peter G.A.   Schoemaker Joop   Homburg Roy   Lambalk Cornelis B.  

Human Reproduction, Vol. 19, Iss. 10, 2004-10 ,pp. : 2206-2215

Oxford University Press

Access to resources Recommend Favorite

Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study

By Cédrin-Durnerin I.  

Human Reproduction, Vol. 19, Iss. 9, 2004-09 ,pp. : 1979-1984

Oxford University Press

Access to resources Recommend Favorite

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

By European Middle East Orgalutran® Study Group* The  

Human Reproduction, Vol. 16, Iss. 4, 2001-04 ,pp. : 644-651

Oxford University Press

Access to resources Recommend Favorite

Infertility. Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study

By Janssens R.M.J.   Lambalk C.B.   Vermeiden J.P.W.   Schats R.   Bernards J.M.   Rekers-Mombarg L.T.M.  

Human Reproduction, Vol. 15, Iss. 11, 2000-11 ,pp. : 2333-2340

Oxford University Press

Access to resources Recommend Favorite

Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF

By Kolibianakis E.M.   Zikopoulos K.   Schiettecatte J.   Smitz J.   Tournaye H.   Camus M.   Van Steirteghem A.C.   Devroey P.  

Human Reproduction, Vol. 19, Iss. 11, 2004-11 ,pp. : 2490-2496

Oxford University Press

Access to resources Recommend Favorite